Article
Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.
Journal of virology - 1 Nov 2003
Hann Byron, Balmain Allan
Abstract excerpt
ONYX-015 (dl1520) is an E1B 55-kilodalton protein-deficient replicating adenovirus that is currently in clinical trials as an antitumor agent. On the basis of the observation that the E1B 55kD gene product is able to bind to and inactivate p53, ONYX-015's mechanism of action is proposed to involve selective replication in and killing of p53-deficient cells. While its efficacy as a therapeutic agent appears...
Topics
- Adenoviridae
- Adenovirus E1B Proteins
- Adenoviruses, Human
- Bronchi
- Cells, Cultured
- Epithelial Cells
- Gene Expression Regulation, Viral
- Humans
- Mutation
- Tumor Suppressor Protein p53
- Viral Vaccines
- Virus Replication
